Skip to main content
Top

Breast Cancer Research

1999 - 2025
Volumes
140
Issues
Chevron right icon
Issue 1/2025
Latest issue

About this journal

Breast Cancer Research is the highest ranking breast cancer-specific title in the top quartile of oncology journals worldwide. Primarily publishing original research, literature reviews, and invited editorials, the journal also publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials. Breast Cancer Research publishes content on the following topics: Clinical Interventions; Cellular or Molecular Pathogenesis; Pathology; Genomics and High-throughput Technologies; Mammary Gland Biology; Imaging; Screening & Prevention; and Epidemiology.

Metadata
Title
Breast Cancer Research
Coverage
Volume 1/1999 - Volume 27/2025
Publisher
BioMed Central
Electronic ISSN
1465-542X
Journal ID
13058

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more